We are an R&D biotech that offers accelerating, high value pipeline co-creation partnerships and comprehensive CRO/CDMO services – always striving for highest quality, capital efficient execution of R&D programs from disease understanding towards IND, Phase 1, and beyond.
Our expertise is vast, encompassing a wide range of therapeutic and disease areas, with a particular emphasis on small molecules and biotherapeutics. We pride ourselves on our ability to navigate the complexities of drug discovery and development, ensuring that our partners benefit from our extensive knowledge and experience.
We leverage our industrialized, AI-powered proprietary R&D platforms such as PanOmics and iPSC technologies to drive better disease understanding and human relevance. We deploy AI and continuous manufacturing technology to allow better access to high-quality biotherapeutics. Our state-of-the-art R&D value chain, combined with highly flexible partnering business models, accelerates medicines that matter at industry-leading efficiency and cost effectiveness.
With our presence spanning the globe and expertise covering every aspect of drug discovery and development, we are readily available wherever you require our services.
Through flexible access to our state-of-the-art CRO/CDMO services across the R&D continuum and more than 4,000 scientific experts spanning all disciplines and disease areas, we are working to deliver success for our partners in the most efficient and cost-effective manner. To create medicines that truly matter. Together.